PHASE 2 STUDY

Clinical trials for PHASE 2 STUDY explained in plain language.

Never miss a new study

Get alerted when new PHASE 2 STUDY trials appear

Sign up with your email to follow new studies for PHASE 2 STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

Under-the-skin shot aims to wipe out hidden leukemia cells

Disease control Not yet recruiting

This study tests whether giving blinatumomab as a shot under the skin can safely control small amounts of leftover leukemia (measurable residual disease) in adults with B-cell acute lymphoblastic leukemia. About 40 participants will receive the drug to see if it prevents the canc…

Matched conditions: PHASE 2 STUDY

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 17, 2026 03:46 UTC

PHASE 2 STUDY

Get alerted when new PHASE 2 STUDY trials appear

Under-the-skin shot aims to wipe out hidden leukemia cells